AnnouncementMarch 2
Company Operations in Response to Partial Lifting of COVID-19 Imposed State of Emergency.
Our sincere condolences to victims of COVID-19, and we hope for the quick recovery of those who have been infected. We also offer sincere gratitude towards healthcare professionals on the forefront to treat patients, and everyone helping to support the community infrastructure.
Responding to the Japanese Government’s decision to lift the state of emergency in six prefectures (excluding the metropolitan area), PHC Holdings Corporation (headquarters: Tokyo, Japan) will be reopening several company sites from March 2. However, as we prioritize the safety of customers and employees, in prefectures still subject to the state of emergency, employees will continue to work from home in principle. At other sites in Japan where our offices are open, employees will continue to work from home as much as possible. When a customer visit is required, upon receipt of the customer’s consent, the visiting employee will strictly implement infection prevention measures such as temperature measurement, wearing of face masks, hand-washing, etc.
· Site reopening
| PHC Corporation |
Osaka Site (Address: OAP Tower 16F, 1-8-30 Tenmabashi, Kita-ku, Osaka City, Osaka)
[Biomedical Business Unit]
Kinki Sales Office/Pharmacy System Sales Office/Delicart Sales Office
[Medical Information Systems Business Unit]
West Japan Sales Office
Chubu Sales Office (Address: Nagoya Panasonic Building 6F, 1-23-30 Izumi, Higashi-ku, Nagoya City, Aichi)
[Biomedical Business Unit]
Chubu Sales Office/Pharmacy System Sales Office/Delicart Sales Office
Kyushu Sales Office (Address: Riverain Center Building 11F, 3-1 Shimokawabata-machi, Hakata-ku, Fukuoka City, Fukuoka)
[Biomedical Business Unit]
Kyushu Sales Office/Pharmacy System Sales Office
[Medical Information Systems Business Unit]
Kyushu Sales Office |
| PHC Associates Corporation |
Gifu Office (Address: Lapis Tower 8F, 1-2-3 Yabutaminami, Gifu City, Gifu) |
Resuming of operations at other sites will be carefully considered depending on government and local policies and the status of the COVID-19. We appreciate your understanding and apologize for any inconvenience or disruption that you may experience as a result of these closures. Details about our operations for other PHC Group companies will be announced separately by each company and we ask you to refer to each company‘s website for further information.
The health and safety of our customers, patients, employees and their families are most important to us and we will continue to further strengthen measures to prevent internal and external spread of the infection, while working to ensure stable supply for customers and patients who rely on our products and services.